The Medicare Prescription Drug, Improvement, and Modernization Act

Prescription drugs and academic medicine

Stanley K. Frencher, Sharon Glied

Research output: Contribution to journalReview article

Abstract

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides universally available prescription drug benefits to elderly and disabled Medicare beneficiaries for the first time. This paper first discusses three controversial features of this legislation: (1) the form of the prescription drug benefit package; (2) the use of competing private plans; and (3) the uncertainty about the future cost of the new prescription drug benefit. The paper then evaluates the implications for academic medicine of the prescription drug benefit and other MMA legislative provisions aimed at improving the quality of medical practice and shifting away from acute care. Ultimately, the health of seniors and the efficient use of public funds in the new prescription drug benefit depend centrally on the prescribing practices of physicians. Academic medicine should turn its attention to training the next generation of physicians to be more effective agents and advocates for their patients in their use of pharmaceuticals.

Original languageEnglish (US)
Pages (from-to)812-816
Number of pages5
JournalAcademic Medicine
Volume81
Issue number9
DOIs
StatePublished - 2006

Fingerprint

Prescription Drugs
Medicare
Social Change
modernization
medication
act
Medicine
medicine
drug
physician
Physicians
Financial Management
medical practice
Legislation
pharmaceutical
Uncertainty
legislation
uncertainty
Costs and Cost Analysis
Health

ASJC Scopus subject areas

  • Medicine(all)
  • Education

Cite this

The Medicare Prescription Drug, Improvement, and Modernization Act : Prescription drugs and academic medicine. / Frencher, Stanley K.; Glied, Sharon.

In: Academic Medicine, Vol. 81, No. 9, 2006, p. 812-816.

Research output: Contribution to journalReview article

@article{b23e01727b0f47719bc40a20e9b4d4d2,
title = "The Medicare Prescription Drug, Improvement, and Modernization Act: Prescription drugs and academic medicine",
abstract = "The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides universally available prescription drug benefits to elderly and disabled Medicare beneficiaries for the first time. This paper first discusses three controversial features of this legislation: (1) the form of the prescription drug benefit package; (2) the use of competing private plans; and (3) the uncertainty about the future cost of the new prescription drug benefit. The paper then evaluates the implications for academic medicine of the prescription drug benefit and other MMA legislative provisions aimed at improving the quality of medical practice and shifting away from acute care. Ultimately, the health of seniors and the efficient use of public funds in the new prescription drug benefit depend centrally on the prescribing practices of physicians. Academic medicine should turn its attention to training the next generation of physicians to be more effective agents and advocates for their patients in their use of pharmaceuticals.",
author = "Frencher, {Stanley K.} and Sharon Glied",
year = "2006",
doi = "10.1097/00001888-200609000-00009",
language = "English (US)",
volume = "81",
pages = "812--816",
journal = "Academic Medicine",
issn = "1040-2446",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - The Medicare Prescription Drug, Improvement, and Modernization Act

T2 - Prescription drugs and academic medicine

AU - Frencher, Stanley K.

AU - Glied, Sharon

PY - 2006

Y1 - 2006

N2 - The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides universally available prescription drug benefits to elderly and disabled Medicare beneficiaries for the first time. This paper first discusses three controversial features of this legislation: (1) the form of the prescription drug benefit package; (2) the use of competing private plans; and (3) the uncertainty about the future cost of the new prescription drug benefit. The paper then evaluates the implications for academic medicine of the prescription drug benefit and other MMA legislative provisions aimed at improving the quality of medical practice and shifting away from acute care. Ultimately, the health of seniors and the efficient use of public funds in the new prescription drug benefit depend centrally on the prescribing practices of physicians. Academic medicine should turn its attention to training the next generation of physicians to be more effective agents and advocates for their patients in their use of pharmaceuticals.

AB - The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) provides universally available prescription drug benefits to elderly and disabled Medicare beneficiaries for the first time. This paper first discusses three controversial features of this legislation: (1) the form of the prescription drug benefit package; (2) the use of competing private plans; and (3) the uncertainty about the future cost of the new prescription drug benefit. The paper then evaluates the implications for academic medicine of the prescription drug benefit and other MMA legislative provisions aimed at improving the quality of medical practice and shifting away from acute care. Ultimately, the health of seniors and the efficient use of public funds in the new prescription drug benefit depend centrally on the prescribing practices of physicians. Academic medicine should turn its attention to training the next generation of physicians to be more effective agents and advocates for their patients in their use of pharmaceuticals.

UR - http://www.scopus.com/inward/record.url?scp=33748284662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748284662&partnerID=8YFLogxK

U2 - 10.1097/00001888-200609000-00009

DO - 10.1097/00001888-200609000-00009

M3 - Review article

VL - 81

SP - 812

EP - 816

JO - Academic Medicine

JF - Academic Medicine

SN - 1040-2446

IS - 9

ER -